| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-11 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-11 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-11 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.24 | 7e-11 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-10 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-09 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |